Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease
Objectives To investigate if non-alcoholic fatty liver disease (NAFLD) impacts mortality and adverse outcomes for individuals with chronic kidney disease (CKD).Design Systematic review.Data sources PubMed, EMBASE and Web of Science were searched up to 1 February 2020 with no restriction on the earli...
Main Authors: | Paul Roderick, Julie Parkes, Theresa Hydes, Ryan Buchanan, Oliver J Kennedy, Simon Fraser |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e040970.full |
Similar Items
-
Coffee, caffeine and non-alcoholic fatty liver disease?
by: Oliver John Kennedy, et al.
Published: (2016-05-01) -
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?
by: Theresa Hydes, et al.
Published: (2021-02-01) -
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States
by: James M. Paik, et al.
Published: (2020-06-01) -
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
by: Bilon Khambu, et al.
Published: (2018-09-01) -
Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
by: Xiaoyan Cai, et al.
Published: (2021-06-01)